ISAAC Resources - ISAAC Phase Four
ISAAC Phase Four is the development and expansion of the scope of the ISAAC website and the creation of this resources section for ISAAC collaborators especially those in low and middle income countries. Management guidelines and other resources will be listed here. Management guidelines which appear on this website are free of pharmaceutical industry sponsorship.
Do you know of any such guidelines?
More guidelines for children which were not sponsored by the pharmaceutical industry will be added to the ISAAC website as they become available. If you know of any such guidelines please contact Eamon Ellwood.
European Respiratory Monograph
The European Respiratory Society (ERS) has recently published the Paediatric Asthma issue of its quarterly book series, the European Respiratory Monograph (ERM). The issue is Guest Edited by leaders in the field Professor Kai-Håkon Carlsen and Professor Jorrit Gerritsen, who have brought together distinguished pulmonologists to provide a comprehensive review of paediatric asthma. All aspects of paediatric asthma are covered, from birth to the start of adulthood, and the issue includes chapters on: asthma phenotypes; physical exercise; food allergy and anaphylaxis; genetics and epigenetics; pollution; asthma treatment; and psychological factors. This issue of the ERM book series should prove a useful resource in daily clinical practice, and it is hoped that young pulmonologists in particular will find this a source of inspiration in their future work.
ERS members can freely access the Paediatric Asthma issue online at http://erspublications.com/content/paediatric-asthma. To purchase a print copy of the issue or to find out more about the ERM, contact email@example.com
Global Asthma Report 2011
Lectures by ISAAC Steering Committee members
ISAAC 20 Year Anniversary Symposium - Auckland 2011
The ISAAC 20 Year Anniversary Symposium was held in the Fisher and Paykel Auditorium, Owen G Glenn Building, The University of Auckland on Thursday 27th of January 2011
Auckland Medical Research Foundation Public Lecture:
Asthma and allergies: Where in the world are we now?
Professor Innes Asher shared the highlights of the ISAAC work and recent Symposium at this public lecture hosted by the Auckland Medical Research Foundation. In this lecture Professor Asher highlighted the changes
in thinking about asthma and allergies over the last 20 years.
download slides | view presentation
Auckland Starship Childrens Hospital Paediatric Update
Auckland Starship Childrens Hospital Paediatric Update October 2010. View Professor Innes Asher’s presentation on ‘Asthma and allergies - where in the world have we got to? ISAAC from 1991 to 2010’.
ATS Conference New Orleans 2010
American Thoracic Society International Conference in New Orleans May 2010. View Professor Innes Asher’s presentation on ‘Asthma Disparities: a Global View’.
ISAAC Symposium - Mérida 2009
The ISAAC symposium was held in the Manuel Cepeda Peraza Auditorium in the Central Building of the Autonomous University of Yucatan (Universidad Autónoma de Yucatán) on Saturday 28th of November 2009
News article from University of Yucatan
The Symposium was hosted by Professor Manuel Baeza Bacab, the ISAAC National Co-ordinator for Mexico, and officially opened by the Director of the university, Alfredo Dájer Abimerhi, MVZ M. Phil. Lectures of ISAAC findings in various aspects of allergic diseases were given by 6 members of the ISAAC Steering Committee. Pdf files of these presentations can be downloaded below.
Allergy, Genetics and Environment.
Alergia, Genética y Ambiente.
Professor Neil Pearce
World-Wide Map of the Prevalence of Rinoconjunctivitis in Children.
Mapa Mundial de la prevalencia de Rinoconjunctivitis en Niños.
Professor Luis García-Marcos
Asthma in Latin America.
Asma en América Latina.
Professor Javier Mallol
Global Epidemiology of Allergic Diseases.
Epidemiología Global de las Enfermedades Alérgicas.
Professor Innes Asher
Professor Hywel Williams
Hygiene: Relationship between Allergic Diseases and
Higiene: Relación entre Enfermedades Alérgicas e Infección.
Professor David Strachan
Asthma - Indigenous Resources
Asthma management interventions
Asthma management intervention and evaluation in a developing country
Sunia Foliaki, Toakase Fakakovikaetau, Wendyl D'Souza, Sione Latu, Viliami Tutone, Soo Cheng, Neil Pearce. Reduction in asthma morbidity following a community-based asthma self-management programme in Tonga. International Journal of Tuberculosis and Lung Disease 2008; 13(1):142–147. Contact: Dr Sunia Foliaki S.Foliaki@massey.ac.nz
DermNet NZ was established by the New Zealand Dermatological Society, the national association of New Zealand registered dermatologists, to provide information about skin diseases, conditions and treatment for patients and their health professionals. http://dermnetnz.org/
This Manual produced by Prof. Hywel C. Williams at the Centre of Evidence Based Dermatology in Nottingham, UK, is designed to aid in examining study participants physically for flexural eczema. It consists of an online set of training images and a quality control test for fieldworkers to ensure standardisation of study methods. It can be found at: http://www.nottingham.ac.uk/dermatology/eczema/contents.html.
Each year NHS Evidence – skin disorders undertakes an annual evidence update on atopic eczema. The update includes new guidelines and new systematic reviews published in the preceding year, and involves a detailed commentary of the clinical implications of the new evidence by Hywel Williams and other colleagues
Michelle Foisy, Robert J. Boyle, Joanne R. Chalmers, Eric L. Simpson, Hywel C. Williams. The prevention of eczema in infants and children: an overview of Cochrane and non-Cochrane reviews Evidence-Based Child Health: A Cochrane Review Journal Volume 6, Issue 5, pages 1322–1339, September 2011
The Global Resource for Eczema Trials (GREAT) is an international collection of all randomized controlled trials published since the year 2000 that is free for anyone to use.
A quick instrument to measure those aspects about eczema severity that matter to patients
– for use in a clinical setting to be filled in by parents before consultation
The Harmonising Outcome Measures for Eczema project is all about trying to reduce the current long list of outcome measures used in eczema clinical trials to 3 or 4 measures that all future trials can use. Many of the previous scoring systems for eczema have never been validated properly, and it is almost impossible to make any sense of the trial evidence base since different studies have used different outcomes. The HOME project hopes to come up with a list of core outcome measures that should be measured in all future eczema trials.
HOME Website (http://www.homeforeczema.org)
Other Useful Links
The Asthma Drug Facility provides affordable access for low and middle income countries to quality assured essential asthma drugs. It was established by the International Union Against Tuberculosis and Lung Disease (IUATLD) with the support of partners such as the World Health Organization (WHO). In addition to the lower the cost of essential asthma medicines, ADF offers technical assistance and support and a strategy for management of asthma to medical practitioners in low and middle income countries.
ADF Website (http://www.globaladf.org)
The Asthma Foundation of New Zealand is New Zealand’s not-for-profit sector authority on asthma and other respiratory illnesses
The International Study of Wheezing in Infants (Estudio Internacional de Sibilancias en Lactantes [EISL]) English | Spanish
EISL is an international cross-sectional multi-centre study designed to assess the prevalence, severity and other factors related to infant wheezing during the first year of life in Latin America and the Iberian Peninsula. EISL has Spanish and English language web sites.
The report of the WAO Nomenclature Review Committee, updating the EAACI Nomenclature Position Statement published in 2001, was published in the Journal of Allergy and Clinical Immunology in May 2004 (J Allergy Clin Immunol 2004; 113: 832-6). The aim of the report is to present a globally acceptable nomenclature for allergic diseases, with the ultimate goal of improving communication in the field of allergy. The nomenclature can be used independently of target organ or patient age group, and is based on the mechanisms which initiate and mediate allergic reactions. As knowledge about basic causes and mechanisms continues to improve, the nomenclature will be reviewed and updated on a triennial basis. This web page includes a summary of the terminology in 23 languages.
Below are links to some useful articles on ISAAC Data entry and Data analysis written by members of the ISAAC International Data Centre. These articles were published in the bi-annual ISAAC newsletter.
ISAAC Phase Three Data Entry - Part2: Epi-Info - Important features you may need to know ISAAC Newsletter July 2002